CAS: 1030769-75-5
SRI 37892
CAS:1030769-75-5
SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell …
Formula:
C26H19N5O2S
Purity:
98.92%
Color and Shape:
Liquid
Molecular weight:
465.53
Ref: TM-T9662
| 1mg | 378.00 € | ||
| 5mg | 922.00 € | ||
| 10mg | 1,225.00 € | ||
| 25mg | 1,853.00 € | ||
| 50mg | 2,490.00 € | ||
| 100mg | 3,353.00 € | ||
| 1mL*10mM (DMSO) | 1,074.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Ref: 54-BUP07634
| 25mg | 2,509.00 € | ||
| 50mg | 3,369.00 € | ||
| 100mg | 4,539.00 € | ||
| 200mg | 5,611.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
![4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide](https://static.cymitquimica.com/products/3D/thumb/FRB76975.jpg)
4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide
Controlled ProductCAS:1030769-75-5
Please enquire for more information about 4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide including the price, delivery time and more detailed …
Formula:
C26H19N5O2S
Purity:
Min. 95%
Molecular weight:
465.5 g/mol
Ref: 3D-FRB76975
| 25mg | 987.00 € | ||
| 50mg | 1,295.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
